Imatron CT Scanner Picked For NIH Cardiovascular Disease Screening Study
This article was originally published in The Gray Sheet
Executive SummaryImatron says the selection of its Ultrafast electron beam computed tomography (EBCT) scanner by the National Heart, Lung and Blood Institute for an upcoming screening study cements the scanner's position as the "gold standard" for assessment of baseline cardiac risk.
You may also be interested in...
TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.